Key result
Supportive therapy achieves complete serotonin syndrome remission within 24 hours in a single case.
Why the study?
Serotonin syndrome diagnosis is challenging due to nonspecific signs and symptoms, and its incidence is rising alongside increasing antidepressant use.
Case Report (n=1)
Serotonin syndrome is an increasingly common, potentially fatal clinical diagnosis that requires prompt recognition and supportive treatment.
Single case of rapid remission with supportive care in serotonin syndrome does not change practice; leaves open need for prospective validation.
Serotonin syndrome (SS) is an entity caused by interference with the serotonin metabolism and/or by medications that act as serotonin receptor agonists. The signs and symptoms are nonspecific, making the diagnosis challenging. Treatment depends on the severity of the manifestations. In mild to moderate cases, it typically resolves within the first 24 hours after initiating therapy and discontinuation of the serotoninergic medications. A 42-year-old woman with a previous history of depression was admitted to the hospital due to the voluntary ingestion of multiple tablets of escitalopram 10 mg and venlafaxine 75 mg. Physical examination showed a hyperthermic and diaphoretic patient. Tremor, agitation, bilateral ocular clonus, and spontaneous inferior limb clonus were also present. Hunter's criteria were applied, and the diagnosis of SS was assumed. Supportive and symptomatic treatments were initiated. The evolution was benign, with symptomatic remission in the first 24 hours. In the last decades, a large increase in the use of antidepressants was noted, and, as such, defining SS as rare is no longer appropriate. Delaying the treatment can dictate an increase in morbidity and mortality. It is important to highlight that the diagnosis is mainly clinical as diagnostic criteria may miss out on some cases. As such, clinical awareness of SS's multiplicity of presentations is of utmost importance.
No takes yet. Share an insight, caveat, or question.
Monteiro et al. (2023) conducted a case report in Serotonin Syndrome (n=1). Escitalopram and venlafaxine overdose was evaluated on Symptomatic remission. A 42-year-old woman with serotonin syndrome following an intentional overdose of escitalopram and venlafaxine achieved complete symptomatic remission within 24 hours of supportive therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: